Bradley S J, Weaver D W, Bouwman D L
Department of Surgery, Wayne State University School of Medicine, Detroit, Michigan.
Am Surg. 1990 Jul;56(7):428-32.
The surgical management of lobular carcinoma in situ (LCIS) and ductal carcinoma in situ (DCIS) remains controversial. For in situ breast cancer local excision (LE), local excision and radiation therapy (LERT) and mastectomy (MAST) have all been advocated. A search of the English literature found 13 reports concerning the surgical management of LCIS and 12 reports concerning the management of DCIS. The data were combined in a meta-analysis of outcome. As expected, recurrence rates following LE with both LCIS 8.4%) and DCIS (17%) are high. However,the overall mortality following mastectomy for recurrence, LCIS (2.8%) and DCIS (2.3%) does not differ statistically from those treated initially with mastectomy for LCIS (0.9%) and DCIS (1.7%). We conclude from these data that local recurrence after breast conserving procedures for in situ breast cancer does not carry an ominous prognosis. This knowledge should aid in planning individual therapy.
小叶原位癌(LCIS)和导管原位癌(DCIS)的手术治疗仍存在争议。对于原位乳腺癌,局部切除(LE)、局部切除加放射治疗(LERT)和乳房切除术(MAST)均有人主张。检索英文文献发现13篇关于LCIS手术治疗的报告和12篇关于DCIS治疗的报告。将这些数据合并进行结果的荟萃分析。不出所料,LCIS(8.4%)和DCIS(17%)局部切除后的复发率都很高。然而,因复发而行乳房切除术后,LCIS(2.8%)和DCIS(2.3%)的总体死亡率与最初因LCIS(0.9%)和DCIS(1.7%)而行乳房切除术的患者相比,在统计学上并无差异。从这些数据我们得出结论,原位乳腺癌保乳手术后的局部复发并不预示着预后不良。这一认识应有助于制定个体化治疗方案。